Comparing Caplyta vs Effexor
| Caplyta (lumateperone) | Effexor (venlafaxine) |
|
|---|
| Caplyta (lumateperone) | Effexor (venlafaxine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Caplyta is an atypical antipsychotic that is used to treat adults with schizophrenia or depression associated with bipolar disorder. Sleepiness is the most common side effect and it should not be... View more |
Prescription only
Effexor is an antidepressant that may cause a discontinuation syndrome if abruptly stopped after long-term administration. Prescribed for Autism, Major Depressive Disorder, Depression, Bulimia... View more |
||||||||
| More about Caplyta (lumateperone) | More about (venlafaxine) | ||||||||
| Ratings & Reviews | |||||||||
|
Caplyta has an average rating of 6.7 out of 10 from a total of 191 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 28% reported a negative effect. |
Effexor has an average rating of 5.8 out of 10 from a total of 490 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Caplyta side effects |
View all Effexor side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Caplyta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
Other venlafaxine brands include: Effexor XR | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
18 hours |
4 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 607 drugs are known to interact with Caplyta:
|
A total of 705 drugs are known to interact with Effexor:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
December 20, 2019 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
|
N/A |
|||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.